Endocannabinoid levels in patients with Parkinson’s disease with and without levodopa-induced dyskinesias
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Endocannabinoid levels in patients with Parkinson’s disease with and without levodopa-induced dyskinesias
Authors
Keywords
-
Journal
JOURNAL OF NEURAL TRANSMISSION
Volume 127, Issue 10, Pages 1359-1367
Publisher
Springer Science and Business Media LLC
Online
2020-08-14
DOI
10.1007/s00702-020-02240-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cannabidiol and Cannabinoid Compounds as Potential Strategies for Treating Parkinson’s Disease and l-DOPA-Induced Dyskinesia
- (2019) Nilson Carlos Ferreira Junior et al. NEUROTOXICITY RESEARCH
- Dyskinesia matters
- (2019) M. Angela Cenci et al. MOVEMENT DISORDERS
- Recent advances in LC-MS/MS methods to determine endocannabinoids in biological samples: Application in neurodegenerative diseases
- (2018) Camila Marchioni et al. ANALYTICA CHIMICA ACTA
- Identification of metabolite biomarkers for L-DOPA-induced dyskinesia in a rat model of Parkinson’s disease by metabolomic technology
- (2018) Yong Wang et al. BEHAVIOURAL BRAIN RESEARCH
- The expression of cannabinoid type 1 receptor and 2-arachidonoyl glycerol synthesizing/degrading enzymes is altered in basal ganglia during the active phase of levodopa-induced dyskinesia
- (2018) Estefania Rojo-Bustamante et al. NEUROBIOLOGY OF DISEASE
- 2-Arachidonoylglycerol: A signaling lipid with manifold actions in the brain
- (2018) Marc P. Baggelaar et al. PROGRESS IN LIPID RESEARCH
- Levodopa-induced dyskinesia in Parkinson disease: Current and evolving concepts
- (2018) Alberto J. Espay et al. ANNALS OF NEUROLOGY
- L-DOPA-induced dyskinesias, motor fluctuations and health-related quality of life: the COPARK survey
- (2017) S. Perez-Lloret et al. EUROPEAN JOURNAL OF NEUROLOGY
- Endocannabinoid modulation of dopamine neurotransmission
- (2017) Dan P. Covey et al. NEUROPHARMACOLOGY
- Parkinson disease
- (2017) Werner Poewe et al. Nature Reviews Disease Primers
- Co-administration of cannabidiol and capsazepine reduces L-DOPA-induced dyskinesia in mice: Possible mechanism of action
- (2016) Maurício dos-Santos-Pereira et al. NEUROBIOLOGY OF DISEASE
- Cannabinoid-dopamine interactions in the physiology and physiopathology of the basal ganglia
- (2015) Concepción García et al. BRITISH JOURNAL OF PHARMACOLOGY
- Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease
- (2015) Ross B. Mounsey et al. EXPERIMENTAL NEUROLOGY
- Detection of cannabinoid receptors CB1 and CB2 within basal ganglia output neurons in macaques: changes following experimental parkinsonism
- (2014) Salvador Sierra et al. Brain Structure & Function
- Control of synaptic function by endocannabinoid-mediated retrograde signaling
- (2014) Masanobu KANO PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- Genome-wide microarray analysis identifies a potential role for striatal retrograde endocannabinoid signaling in the pathogenesis of experimentall-DOPA-induced dyskinesia
- (2014) Yong Wang et al. SYNAPSE
- The Endocannabinoid System and the Brain
- (2012) Raphael Mechoulam et al. Annual Review of Psychology
- Dynamic changes of anandamide in the cerebrospinal fluid of Parkinson's disease patients
- (2010) Valerio Pisani et al. MOVEMENT DISORDERS
- Homeostatic changes of the endocannabinoid system in Parkinson's disease
- (2010) Valerio Pisani et al. MOVEMENT DISORDERS
- Systematic review of levodopa dose equivalency reporting in Parkinson's disease
- (2010) Claire L. Tomlinson et al. MOVEMENT DISORDERS
- In vivo pharmacology of endocannabinoids and their metabolic inhibitors: Therapeutic implications in Parkinson's disease and abuse liability
- (2009) Andrea Giuffrida et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- The Unified Dyskinesia Rating Scale: Presentation and clinimetric profile
- (2008) Christopher G. Goetz et al. MOVEMENT DISORDERS
- Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results
- (2008) Christopher G. Goetz et al. MOVEMENT DISORDERS
- Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum
- (2008) Mauro Maccarrone et al. NATURE NEUROSCIENCE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now